Thursday, July 9, 2020
Home Life Style Health & Fitness Experimental Drug for Parkinson's Shows Progress

Experimental Drug for Parkinson’s Shows Progress

New drug for Parkinson's shows promise

An experimental drug has shown promise in treatment of debilitating movement problems in people with Parkinson’s disease. This is the latest health news.

The researchers investigated the effect of the drug NLX-112 on dyskinesia, a common side effect experienced by people with Parkinson’s who have been taking levodopa-based medications for several years. Levodopa is generally used as a dopamine replacement agent for the treatment of Parkinson’s.

The drug works by targeting serotonin cells inside the brain which are believed to contribute to the development of dyskinesia, by releasing dopamine in an erratic manner. It aims to reduce dyskinesia by decreasing the amount of dopamine the cells release, said the study published online in the journal Neuropharmacology.

The research was carried out by US-based biotech company Neurolixis with funding from Parkinson’s UK, a charity.

Parkinson's drug
The drug works by targeting serotonin cells inside the brain which are believed to contribute to the development of dyskinesia, by releasing dopamine in an erratic manner. (Representational Image). Pixabay

“This promising research on NLX-112 offers hope that we can find a treatment that can tackle dyskinesia, which can make everyday tasks, such as eating, writing and walking, extremely difficult,” said Arthur Roach, Director of Research at Parkinson’s UK.

“People with Parkinson’s tell us it is one of the most critical issues that impacts quality of life so we’re delighted that this project is progressing so positively,” Roach said.

Anyone can get Parkinson’s, young or old. Parkinson’s is what happens when the brain cells that make dopamine start to die. There are over 40 symptoms, from tremor and pain to anxiety. Some are treatable, but the drugs can have serious side effects. It gets worse over time and there’s no cure yet.

Around half of all people with Parkinson’s will experience dyskinesia after just five years of taking levodopa, and up to 80 per cent of people will experience it after ten years of taking the medication.

In this study, the drug NLX-112 was tested in monkeys with Parkinson’s-like symptoms. The monkeys had developed the side effect of dyskinesia in response to levodopa treatment in a similar way to many people with Parkinson’s.

The study looked at the effect of NLX-112 both on its own and in combination with levodopa, to understand how it impacted both dyskinesia and Parkinson’s symptoms.

The results showed that NLX-112 successfully reduced dyskinesia and crucially, did not significantly reduce the effectiveness of levodopa, which many other similar drugs do.

Also Read- 2 Experimental Drugs Fail to Prevent Alzheimer’s Disease

When NLX-112 was used on its own (without levodopa), it again improved movement problems.

These promising results suggest that NLX-112 has potential as a future treatment for not only reducing dyskinesia, but also for improving the movement symptoms of Parkinson’s, said the study. (IANS)

STAY CONNECTED

18,993FansLike
362FollowersFollow
1,782FollowersFollow

Most Popular

49% Indians Feel Chinese Firms Should be Allowed to Sell Products: Survey

A survey has found that around 49 per cent of its respondents feel that Chinese companies should be allowed to sell products in India,...

People Opting for Domestic Trips Post-Pandemic

By Siddhi Jain After a long stretch of staying-at-home, consumers are quick to show willingness to go out and travel again, albeit within driving distance...

eRaksha Competition 2020: Creating Cyber Awareness Among Youth

Online learning has become the need of the hour and the most viable resource that has come to the aid of children and their...

The Roots of the Conflict in South Asia and the Escalation of Tensions

By Amin Bagheri Territorial wars have always existed in the world, and sometimes the resolution of disputes has lasted for centuries, millions of people have...

New Google Feature to Provide Quick Facts About Images You Search

Google on Wednesday announced a new feature that will make it easy to find quick facts about what people see on Google images in...

People are 30% More Likely to Donate When Reminded of Own Mortality

People are 30 per cent more likely to donate their assets when faced with their own mortality, say researchers. The study, published in the Journal...

Earth’s Magnetic Field May Change 10 Times Faster Than Previously Thought

Scientists using simulations in the lab have revealed that changes in the direction of the Earth's magnetic field may take place 10 times faster...

Cases of Brain Complications Linked to Covid-19 Globally

Cases of brain complications linked to Covid-19 are occurring across the globe, according to a new study, published in the journal The Lancet Neurology. According...

Recent Comments